Merck & Company, Inc. vs Stryker Corporation — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
7.5
Bullish
Quality
Health
Growth
Valuation
Sentiment
MRK
Forward P/E of 11.5× is low relative to sector peers.
SYK
Consensus analyst target of $394.12 is 34% above current price.
Analyst Consensus
BUY
Target $129.74 (+15.7%)
27 analysts
BUY
Target $394.12 (+33.7%)
26 analysts
Fundamentals
MRK
SYK
31.5×
Trailing P/E
35.1×
11.5×
Forward P/E
17.6×
13.6%
Profit Margin
13.2%
76.6%
Gross Margin
64.7%
—
ROE
15.2%
4.9%
Revenue Growth
2.6%
—
Earnings Growth
14.2%
0.28
Beta
0.93
—
Price / Book
—
$277.0B
Market Cap
$112.9B
$73 – $125
52-Week Range
$295 – $405
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →